241 related articles for article (PubMed ID: 30451396)
1. The pathological outcome of ThinPrep Pap tests diagnosed as glandular cell abnormalities alone versus combined glandular and squamous abnormalities.
Harbhajanka A; Chahar S; Michael CW
Diagn Cytopathol; 2019 Feb; 47(2):88-93. PubMed ID: 30451396
[TBL] [Abstract][Full Text] [Related]
2. Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?
Harbhajanka A; Dahoud W; Michael CW
Diagn Cytopathol; 2019 Oct; 47(10):1028-1036. PubMed ID: 31359607
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
4. Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.
Goetz LH; Evans HL; Armylagos D; Zhou H; Mody DR; Schwartz MR; Ge Y
J Am Soc Cytopathol; 2024; 13(3):227-232. PubMed ID: 38401997
[TBL] [Abstract][Full Text] [Related]
5. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
6. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of atypical glandular cells in Pap tests: An analysis of more than 3000 cases at a large academic women's center.
Pradhan D; Li Z; Ocque R; Patadji S; Zhao C
Cancer Cytopathol; 2016 Aug; 124(8):589-95. PubMed ID: 27115423
[TBL] [Abstract][Full Text] [Related]
9. Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2015 Nov; 43(11):870-8. PubMed ID: 26174002
[TBL] [Abstract][Full Text] [Related]
10. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells.
Zhao C; Florea A; Austin RM
Arch Pathol Lab Med; 2010 Jan; 134(1):103-8. PubMed ID: 20073612
[TBL] [Abstract][Full Text] [Related]
12. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
13. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
Alexander C; White M; Maleki Z; Rodriguez EF
Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
[TBL] [Abstract][Full Text] [Related]
14. The Cellient automated cell block system is useful in the differential diagnosis of atypical glandular cells in Papanicolaou tests.
Xing W; Hou AY; Fischer A; Owens CL; Jiang Z
Cancer Cytopathol; 2014 Jan; 122(1):8-14. PubMed ID: 23963870
[TBL] [Abstract][Full Text] [Related]
15. Eleven-year review of data on Pap smears in Saudi Arabia: We need more focus on glandular abnormalities!
Nasser H; AlAyyaf M; Atallah A; Aminulislam M; Rizwan L; Aodah A; Alkahtani Y; Alshammari H; Alsayed A; Szpunar S
Ann Saudi Med; 2017; 37(4):265-271. PubMed ID: 28761025
[TBL] [Abstract][Full Text] [Related]
16. Metastatic melanoma of the uterine cervix diagnosed on cervical Pap smear: Case report and literature review.
Shachner TR; Van Meter SE
Diagn Cytopathol; 2018 Dec; 46(12):1045-1049. PubMed ID: 30354020
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of atypical glandular cells of undetermined significance.
Geier CS; Wilson M; Creasman W
Am J Obstet Gynecol; 2001 Jan; 184(2):64-9. PubMed ID: 11174481
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic Follow-Up of Women with Inadequate ThinPrep™ Cervical Pap Tests and Positive High-Risk Human Papillomavirus Test Results.
Kir G; Ozen S
Acta Cytol; 2023; 67(5):533-538. PubMed ID: 37494923
[TBL] [Abstract][Full Text] [Related]
19. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
[TBL] [Abstract][Full Text] [Related]
20. Negative computer-imaged ThinPrep Pap test and positive hybrid capture2 HPV co-testing results: A quality assurance review.
Rao R; Molina D; Halligan AM; Vakil B; Alperstein SA; Hoda RS
Diagn Cytopathol; 2015 Sep; 43(9):763-9. PubMed ID: 26173579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
